E-ISSN 2636-834X
 
2023, Vol: 13, Issue: 1
13/1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

COPYRIGHT FORM

Case Report 


Trihexyphenidyl triggered hypomania in a bipolar patient

Eren Yıldızhan, Serap Batmaz, Nazan Karagöz Sakallı, Erhan Kurt.

Abstract
We observed a case of tardive dyskinesia after regular use of low dose chlorpromazine. An anticholinergic agent; trihexyphenidyl (THX) was used to treat the tardive dyskinesia. Treatment response was satisfactory, but brief hypomanic episodes occured. Because the patient was symptom free for long periods of time, we suspected that THX may have a negative effect on the course of the disease or it may have induced hypomania. These episodes were controled with short term use of olanzapine. When the dose of THX was further increased, we determined elevation of mood. History of bipolar disorder in his family and having the early onset type of bipolar disorder were features of our case making the tardive movement disorder more likely. Although THX may be an effective option in tardive dyskinesia, change in the course of the disease in bipolar patients may be a possibility.

Key words: trihexyphenidyl, hypomania, tardive dyskinesia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Eren Yıldızhan
Articles by Serap Batmaz
Articles by Nazan Karagöz Sakallı
Articles by Erhan Kurt
on Google
on Google Scholar


REFERENCES
1. Waddington JL, Youssef HA. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium. Am J Psychiatry 1988;145:613-616. [Pubmed]   
2. Othmer E, Desouza CM, Penick EC Indicators of mania in depressed outpatients: a retrospective analysis of data from the Kansas 1500 study. J Clin Psychiatry 2007;68(1):47-51 [DOI via Crossref]   
3. Kane JM, Jeste DV, Barnes TRE. Tardive dyskinesia in affective disorders. J Clin Psychiatry 1999;60(Suppl 5):43-47. [Pubmed]   
4. Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WeJr. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 1979;135:509-514.
5. Hayashi Y, Ohyagi Y, Inoue I et al. A case of amoxapine induced tardive dystonia successfully treated with a low dose anticholinergic agent. Rinsho Shinkeigaku 2000;40(4):367-371 [Pubmed]   
6. Fleischhacker WW, Barnas C, Gunther V, Meise U, Stuppack C, Unterweger B Mood-altering effects of biperiden in healthy volunteers. J Affect Disord 1987;12(2):153-157. [DOI via Crossref]   
7. Clarke LA, Cassidy CW, Catalano MC Psychosis induced by smoking cessation clinic administered anticholinergic overload. Ann Clin Psychiatry 2004;16(3):171-175. [DOI via Crossref]   
8. Tollefson GD, Senogles S A cholinergic role in the mechanism of lithium in mania. Biol Psychiatry 1983;18(4):467-479. [Pubmed]   
9. Koszewska I, Rybakowski JK Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic antidepressant drugs. Neuropsychobiology 2009; 59(1): 12-6. [DOI via Crossref]    [Pubmed]   

How to Cite this Article
Pubmed Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. Trihexyphenidyl triggered hypomania in a bipolar patient. PBS. 2012; 2(2): 77-79. doi:10.5455/jmood.20120406022709

Web Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. Trihexyphenidyl triggered hypomania in a bipolar patient. https://www.pbsciences.org/?mno=8716 [Access: March 28, 2023]. doi:10.5455/jmood.20120406022709

AMA (American Medical Association) Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. Trihexyphenidyl triggered hypomania in a bipolar patient. PBS. 2012; 2(2): 77-79. doi:10.5455/jmood.20120406022709


Vancouver/ICMJE Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. Trihexyphenidyl triggered hypomania in a bipolar patient. PBS. (2012), [cited March 28, 2023]; 2(2): 77-79. doi:10.5455/jmood.20120406022709


Harvard Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt (2012) Trihexyphenidyl triggered hypomania in a bipolar patient. PBS, 2 (2), 77-79. doi:10.5455/jmood.20120406022709


Turabian Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. 2012. Trihexyphenidyl triggered hypomania in a bipolar patient. Psychiatry and Behavioral Sciences, 2 (2), 77-79. doi:10.5455/jmood.20120406022709


Chicago Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. "Trihexyphenidyl triggered hypomania in a bipolar patient." Psychiatry and Behavioral Sciences 2 (2012), 77-79. doi:10.5455/jmood.20120406022709


MLA (The Modern Language Association) Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt. "Trihexyphenidyl triggered hypomania in a bipolar patient." Psychiatry and Behavioral Sciences 2.2 (2012), 77-79. Print. doi:10.5455/jmood.20120406022709


APA (American Psychological Association) Style

Eren Yıldızhan, Serap Batmaz, Nazan Karagoz Sakallı, Erhan Kurt (2012) Trihexyphenidyl triggered hypomania in a bipolar patient. Psychiatry and Behavioral Sciences, 2 (2), 77-79. doi:10.5455/jmood.20120406022709


Author LoginReviewer Login
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in Psychiatry and Behavioral Sciences are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2023 Psychiatry and Behavioral Sciences All Rights Reserved. Subject to change without notice from or liability to Psychiatry and Behavioral Sciences.
For best results, please use Internet Explorer or Google Chrome

Contact Information